Common for major surgery, multitrauma, sepsis, and critical illness, is a whole-body inflammation. Tissue injury is able to trigger a generalized inflammatory reaction. Cell death causes release of endogenous structures termed damage associated molecular patterns (DAMPs) that initiate a sterile inflammation. Mitochondria are evolutionary endosymbionts originating from bacteria, containing molecular patterns similar to bacteria. These molecular patterns are termed mitochondrial DAMPs (mDAMPs). Mitochondrial debris released into the extracellular space or into the circulation is immunogenic and damaging secondary to activation of the innate immune system. In the circulation, released mDAMPS are either free or exist in extracellular vesicles, being able to act on every organ and cell in the body. However, the role of mDAMPs in trauma and critical care is not fully clarified. There is a complete lack of knowledge how they may be counteracted in patients. Among mDAMPs are mitochondrial DNA, cardiolipin, N-formyl peptides, cytochrome C, adenosine triphosphate, reactive oxygen species, succinate, and mitochondrial transcription factor A. In this overview, we present the different mDAMPs, their function, release, targets, and inflammatory potential. In light of present knowledge, the role of mDAMPs in the pathophysiology of major surgery and trauma as well as sepsis, and critical care is discussed.
Huber-LangMLambrisJDWardPA. Innate immune responses to trauma. Nat Immunol.2018;19(4):327-341.
2.
MuszynskiJAThakkarRHallMW. Inflammation and innate immune function in critical illness. Curr Opin Pediatr. 2016;28(3):267-273.
3.
Hari MSSummersC. Major surgery and the immune system: from pathophysiology to treatment. Curr Opin Crit Care. 2018;24(6):588-593. doi:10.1097/MCC.0000000000000561
4.
BoeddhaNPBycroftTNadelSHazelzetJA. The inflammatory and hemostatic response in sepsis and meningococcemia. Crit Care Clin. 2020;36(2):391-399.
5.
MaKCSchenckEJPabonMAChoiAMK. The role of danger signals in the pathogenesis and perpetuation of critical illness. Am J Respir Crit Care Med. 2018;197(3):300-309.
6.
AndrieuxPChevillardCCunha-NetoENunesJPS. Mitochondria as a cellular hub in infection and inflammation. Int J Mol Sci.2021;22(21):11338.
7.
Pérez-TreviñoPVelásquezMGarcíaN. Mechanisms of mitochondrial DNA escape and its relationship with different metabolic diseases. Biochim Biophys Acta Mol Basis Dis. 2020;1866(6):165761.
8.
PapeHCTsukamotoTKobbePTarkinIKatsoulisSPeitzmanA. Assessment of the clinical course with inflammatory parameters. Injury. 2007;38(12):1358-1364.
9.
ZhangQRaoofMChenY, et al.Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature. 2010;464(7285):104-107.
10.
ZhangQItagakiKHauserCJ. Mitochondrial DNA is released by shock and activates neutrophils via p38 map kinase. Shock. 2010;34(1):55-59.
11.
PiccaACalvaniRCoelho-JuniorHJMarzettiE. Cell death and inflammation: the role of mitochondria in health and disease. Cells. 2021;10(3):537.
12.
SaganL. On the origin of mitosing cells. J Theor Biol.1967;14(3):255-274. doi:10.1016/0022-5193(67)90079-3
13.
RogerAJMuñoz-GómezSAKamikawaR. The origin and diversification of mitochondria. Curr Biol. 2017;27(21):R1177-R1r92.
14.
HongEEOkitsuCYSmithADHsiehCL. Regionally specific and genome-wide analyses conclusively demonstrate the absence of CpG methylation in human mitochondrial DNA. Mol Cell Biol.2013;33(14):2683-2690.
15.
CloonanSMChoiAM. Mitochondria: commanders of innate immunity and disease?Curr Opin Immunol. 2012;24(1):32-40.
16.
MillsELKellyBO'NeillLAJ. Mitochondria are the powerhouses of immunity. Nat Immunol.2017;18(5):488-498.
17.
IyerSSHeQJanczyJR, et al.Mitochondrial cardiolipin is required for Nlrp3 inflammasome activation. Immunity. 2013;39(2):311-323.
18.
ZhouRYazdiASMenuPTschoppJ. A role for mitochondria in NLRP3 inflammasome activation. Nature. 2011;469(7329):221-225.
19.
CarpH. Mitochondrial N-formylmethionyl proteins as chemoattractants for neutrophils. J Exp Med. 1982;155(1):264-275.
20.
CrouserEDShaoGJulianMW, et al.Monocyte activation by necrotic cells is promoted by mitochondrial proteins and formyl peptide receptors. Crit Care Med. 2009;37(6):2000-2009.
21.
WestAPShadelGSGhoshS. Mitochondria in innate immune responses. Nat Rev Immunol. 2011;11(6):389-402.
22.
NicholasSACoughlanKYasinskaI,et al.Dysfunctional mitochondria contain endogenous high-affinity human toll-like receptor 4 (TLR4) ligands and induce TLR4-mediated inflammatory reactions. Int J Biochem Cell Biol.2011;43(4):674-681.
23.
HuQWoodCRCimenSVenkatachalamABAlwaynIP. Mitochondrial damage-associated molecular patterns (MTDs) are released during hepatic ischemia reperfusion and induce inflammatory responses. PLoS ONE. 2015;10(10):e0140105.
24.
WestAPShadelGS. Mitochondrial DNA in innate immune responses and inflammatory pathology. Nat Rev Immunol. 2017;17(6):363-375.
25.
MuraoAAzizMWangHBrennerMWangP. Release mechanisms of major DAMPs. Apoptosis : Int J Program Cell Death. 2021;26(3-4):152-162.
26.
DeusCMTavaresHBeatrizMMotaSLopesC. Mitochondrial damage-associated molecular patterns content in extracellular vesicles promotes early inflammation in neurodegenerative disorders. Cells. 2022;11(15):2364.
27.
PiccaAGuerraFCalvaniR, et al.Extracellular vesicles and damage-associated molecular patterns: a Pandora's box in health and disease. Front Immunol. 2020;11:601740.
28.
WieckowskiMRGiorgiCLebiedzinskaMDuszynskiJPintonP. Isolation of mitochondria-associated membranes and mitochondria from animal tissues and cells. Nat Protoc. 2009;4(11):1582-1590.
29.
PerroneMCarocciaNGenoveseI, et al.The role of mitochondria-associated membranes in cellular homeostasis and diseases. Int Rev Cell Mol Biol. 2020;350:119-196. doi:10.1016/bs.ircmb.2019.11.002
30.
RieussetJ. Mitochondria-associated membranes (MAMs): an emerging platform connecting energy and immune sensing to metabolic flexibility. Biochem Biophys Res Commun.2018;500(1):35-44.
31.
MissiroliSPatergnaniSCarocciaN, et al.Mitochondria-associated membranes (MAMs) and inflammation. Cell Death Dis.2018;9(3):329.
MarchiSPatergnaniSMissiroliS, et al.Mitochondrial and endoplasmic reticulum calcium homeostasis and cell death. Cell Calcium. 2018;69:62-72.
34.
MedzhitovRJaneway Jr.C. Innate immune recognition: mechanisms and pathways. Immunol Rev.2000;173:89-97.
35.
MeyerALavernyGBernardiL, et al.Mitochondria: an organelle of bacterial origin controlling inflammation. Front Immunol. 2018;9:536.
36.
SirisinhaS. Insight into the mechanisms regulating immune homeostasis in health and disease. Asian Pac J Allergy Immunol. 2011;29(1):1-14.
37.
HamadaATorreCDrancourtMGhigoE. Trained immunity carried by non-immune cells. Front Microbiol. 2018;9:3225. doi:10.3389/fmicb.2018.03225
38.
HansenJDVojtechLNLaingKJ. Sensing disease and danger: a survey of vertebrate PRRs and their origins. Dev Comp Immunol.2011;35(9):886-897.
39.
Rodríguez-NuevoAZorzanoA. The sensing of mitochondrial DAMPs by non-immune cells. Cell Stress. 2019;3(6):195-207.
40.
Yáñez-MóMSiljanderPRAndreuZ, et al.Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles. 2015;4:27066.
41.
AndersonSBankierATBarrellBG, et al.Sequence and organization of the human mitochondrial genome. Nature. 1981;290(5806):457-465.
42.
ClaytonDA. Transcription of the mammalian mitochondrial genome. Annu Rev Biochem.1984;53:573-594.
43.
BonawitzNDClaytonDAShadelGS. Initiation and beyond: multiple functions of the human mitochondrial transcription machinery. Mol Cell.2006;24(6):813-825.
44.
RileyJSTaitSW. Mitochondrial DNA in inflammation and immunity. EMBO Rep.2020;21(4):e49799.
45.
NakahiraKHisataSChoiAM. The roles of mitochondrial damage-associated molecular patterns in diseases. Antioxid Redox Signaling.2015;23(17):1329-1350.
46.
De GaetanoASolodkaKZaniniG,et al.Molecular mechanisms of mtDNA-mediated inflammation. Cells. 2021;10(11):e99238.
47.
RileyJSQuaratoGCloixC, et al.Mitochondrial inner membrane permeabilisation enables mtDNA release during apoptosis. EMBO J. 2018;37(17):222‐230.
48.
NakahiraKHaspelJARathinamVA, et al.Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat Immunol.2011;12(3):222-230.
49.
OkaTHikosoSYamaguchiO, et al.Mitochondrial DNA that escapes from autophagy causes inflammation and heart failure. Nature. 2012;485(7397):251-255.
50.
BliksoenMMarieroLHTorpMK, et al.Extracellular mtDNA activates NF-kappaB via toll-like receptor 9 and induces cell death in cardiomyocytes. Basic Res Cardiol.2016;111(4):42.
51.
MaoYLuoWZhangL, et al.STING-IRF3 triggers endothelial inflammation in response to free fatty acid-induced mitochondrial damage in diet-induced obesity. Arterioscler, Thromb, Vasc Biol.2017;37(5):920-929.
52.
ZhongZLiangSSanchez-LopezE, et al.New mitochondrial DNA synthesis enables NLRP3 inflammasome activation. Nature. 2018;560(7717):198-203.
53.
ShimadaKCrotherTRKarlinJ, et al.Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis. Immunity. 2012;36(3):401-414.
54.
CollinsLVHajizadehSHolmeEJonssonIMTarkowskiA. Endogenously oxidized mitochondrial DNA induces in vivo and in vitro inflammatory responses. J Leukocyte Biol.2004;75(6):995-1000.
55.
WuJSunLChenX,et al.Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA. Science. 2013;339(6121):826-830.
56.
BartonGMKaganJCMedzhitovR. Intracellular localization of toll-like receptor 9 prevents recognition of self DNA but facilitates access to viral DNA. Nat Immunol.2006;7(1):49-56.
57.
MarieroLHTorpM-KHeiestadCM, et al.Inhibiting nucleolin reduces inflammation induced by mitochondrial DNA in cardiomyocytes exposed to hypoxia and reoxygenation. Br J Pharmacol.2019;176(22):4360-4372.
58.
LiuXZhangZRuanJ,et al.Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores. Nature. 2016;535(7610):153-158.
59.
SborgiLRuhlSMulvihillE, et al.GSDMD membrane pore formation constitutes the mechanism of pyroptotic cell death. EMBO J. 2016;35(16):1766-1778.
60.
de BoerESokolovaMQuachHQ, et al.Synthetic oligodeoxynucleotide CpG motifs activate human complement through their backbone structure and induce complement-dependent cytokine release. J Immunol. 2022;209(9):1760-1767.
61.
LamLKMMurphySKokkinakiD, et al.DNA binding to TLR9 expressed by red blood cells promotes innate immune activation and anemia. Sci Transl Med.2021;13(616):eabj1008.
62.
ZuoYYalavarthiSShiH, et al.Neutrophil extracellular traps in COVID-19. JCI Insight. 2020;5(11):365.
HidalgoALibbyPSoehnleinOAramburuIVPapayannopoulosVSilvestre-RoigC. Neutrophil extracellular traps: from physiology to pathology. Cardiovasc Res.2021;44:325‐334.
65.
ThurairajahKBriggsGDBaloghZJ. The source of cell-free mitochondrial DNA in trauma and potential therapeutic strategies. Eur J Trauma Emerg Surg. 2018;44(3):325-334.
66.
ElzanowskaJSemiraCCosta-SilvaB. DNA in extracellular vesicles: Biological and clinical aspects. Mol Oncol. 2021;15(6):1701-1714.
67.
MargrafALudwigNZarbockARossaintJ. Systemic inflammatory response syndrome after surgery: mechanisms and protection. Anesth Analg. 2020;131(6):1693-1707.
68.
DobsonGPMorrisJLBirosEDavenportLMLetsonHL. Major surgery leads to a proinflammatory phenotype: differential gene expression following a laparotomy. Ann Med Surg. 2021;71:102970.
69.
BaysaAFedorovAKondratovK, et al.Release of mitochondrial and nuclear DNA during on-pump heart surgery: kinetics and relation to extracellular vesicles. J Cardiovasc Transl Res. 2019;12(3):184-192.
70.
DiebelLNLiberatiDMLedgerwoodAMLucasCE. Changes in lymph proteome induced by hemorrhagic shock: the appearance of damage-associated molecular patterns. J Trauma Acute Care Surg. 2012;73(1):41-51. discussion 1.
71.
HauserCJSursalTRodriguezEKAppletonPTZhangQItagakiK. Mitochondrial damage associated molecular patterns from femoral reamings activate neutrophils through formyl peptide receptors and P44/42 MAP kinase. J Orthop Trauma. 2010;24(9):534-538.
72.
AswaniAMansonJItagakiK, et al.Scavenging circulating mitochondrial DNA as a potential therapeutic option for multiple organ dysfunction in trauma hemorrhage. Front Immunol. 2018;9:891.
73.
SeiboldTSchönfelderJWeeberF, et al.Small extracellular vesicles propagate the inflammatory response after trauma. Adv Sci (Weinh). 2021;8(24):e2102381. doi:10.1002/advs.202102381
74.
SimmonsJDLeeYLMulekarS, et al.Elevated levels of plasma mitochondrial DNA DAMPs are linked to clinical outcome in severely injured human subjects. Ann Surg.2013;258(4):591-596. discussion 6-8.
75.
ItagakiKKaczmarekELeeYT, et al.Mitochondrial DNA released by trauma induces neutrophil extracellular traps. PLoS ONE. 2015;10(3):e0120549.
76.
RaoofMZhangQItagakiKHauserCJ. Mitochondrial peptides are potent immune activators that activate human neutrophils via FPR-1. J Trauma. 2010;68(6):1328-1332. discussion 32-4.
77.
MarcouxGMagronASutC, et al.Platelet-derived extracellular vesicles convey mitochondrial DAMPs in platelet concentrates and their levels are associated with adverse reactions. Transfusion. 2019;59(7):2403-2414.
78.
BoudreauLHDuchezACCloutierN, et al.Platelets release mitochondria serving as substrate for bactericidal group IIA-secreted phospholipase A2 to promote inflammation. Blood. 2014;124(14):2173-2183.
79.
LubkinDTBishawiMBarbasASBrennanTVKirkAD. Extracellular mitochondrial DNA and N-formyl peptides in trauma and critical illness: a systematic review. Crit Care Med. 2018;46(12):2018-2028.
80.
Walko 3rdTDBolaRAHongJD, et al.Cerebrospinal fluid mitochondrial DNA: a novel DAMP in pediatric traumatic brain injury. Shock. 2014;41(6):499-503.
81.
XiaoWMindrinosMNSeokJ, et al.A genomic storm in critically injured humans. J Exp Med. 2011;208(13):2581-2590.
82.
TschoekeSKErtelW. Immunoparalysis after multiple trauma. Injury. 2007;38(12):1346-1357.
83.
TimmermansKKoxMVanekerM, et al.Plasma levels of danger-associated molecular patterns are associated with immune suppression in trauma patients. Intensive Care Med. 2016;42(4):551-561.
84.
VesterHDargatzPHuber-WagnerSBiberthalerPvan GriensvenM. HLA-DR expression on monocytes is decreased in polytraumatized patients. Eur J Med Res. 2015;20:84.
85.
LeijteGPCustersHGerretsenJ, et al.Increased plasma levels of danger-associated molecular patterns are associated with immune suppression and postoperative infections in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Front Immunol. 2018;9:663.
86.
YasuharaSAsaiASahaniNDMartynJA. Mitochondria, endoplasmic reticulum, and alternative pathways of cell death in critical illness. Crit Care Med. 2007;35(9 Suppl):S488-S495.
87.
SupinskiGSSchroderEACallahanLA. Mitochondria and critical illness. Chest. 2020;157(2):310-322.
88.
NakahiraKKyungSYRogersAJ, et al.Circulating mitochondrial DNA in patients in the ICU as a marker of mortality: derivation and validation. PLoS Med. 2013;10(12):e1001577. discussion e.
89.
KungCTHsiaoSYTsaiTC, et al.Plasma nuclear and mitochondrial DNA levels as predictors of outcome in severe sepsis patients in the emergency room. J Transl Med.2012;10:130.
90.
YamanouchiSKudoDYamadaMMiyagawaNFurukawaHKushimotoS. Plasma mitochondrial DNA levels in patients with trauma and severe sepsis: time course and the association with clinical status. J Crit Care. 2013;28(6):1027-1031.
91.
SchäferSTFrankenLAdamzikM, et al.Mitochondrial DNA: an endogenous trigger for immune paralysis. Anesthesiology. 2016;124(4):923-933.
92.
SchneckEEdingerFHeckerM, et al.Blood levels of free-circulating mitochondrial DNA in septic shock and postsurgical systemic inflammation and its influence on coagulation: a secondary analysis of a prospective observational study. J Clin Med. 2020;9(7):607‐612.
93.
TimmermansKKoxMSchefferGJPickkersP. Plasma nuclear and mitochondrial DNA levels, and markers of inflammation, shock, and organ damage in patients with septic shock. Shock. 2016;45(6):607-612.
94.
StoiberWObermayerASteinbacherPKrautgartnerWD. The role of reactive oxygen species (ROS) in the formation of extracellular traps (ETs) in humans. Biomolecules. 2015;5(2):702-723.
95.
LiRHLTablinF. A comparative review of neutrophil extracellular traps in sepsis. Front Vet Sci. 2018;5:291:e20201012.
96.
IngelssonBSöderbergDStridT, et al.Lymphocytes eject interferogenic mitochondrial DNA webs in response to CpG and non-CpG oligodeoxynucleotides of class C. Proc Natl Acad Sci USA.2018;115(3):E478-Ee87.
97.
HuangSUO'SullivanKM. The expanding role of extracellular traps in inflammation and autoimmunity: the new players in casting dark webs. Int J Mol Sci.2022;23(7).
98.
RadermeckerCDetrembleurNGuiotJ, et al.Neutrophil extracellular traps infiltrate the lung airway, interstitial, and vascular compartments in severe COVID-19. J Exp Med. 2020;217(12):1228‐1241.
99.
DöringYLibbyPSoehnleinO. Neutrophil extracellular traps participate in cardiovascular diseases: recent experimental and clinical insights. Circ Res.2020;126(9):1228-1241.
100.
SaffarzadehMJuenemannCQueisserMA, et al.Neutrophil extracellular traps directly induce epithelial and endothelial cell death: a predominant role of histones. PLoS ONE. 2012;7(2):e32366.
101.
VillanuevaEYalavarthiSBerthierCC, et al.Netting neutrophils induce endothelial damage, infiltrate tissues, and expose immunostimulatory molecules in systemic lupus erythematosus. J Immunol. 2011;187(1):538-552.
102.
McDonaldBDavisRPKimSJ,et al.Platelets and neutrophil extracellular traps collaborate to promote intravascular coagulation during sepsis in mice. Blood. 2017;129(10):1357-1367.
103.
ChenZZhangHQuM, et al.Review: the emerging role of neutrophil extracellular traps in sepsis and sepsis-associated thrombosis. Front Cell Infect Microbiol. 2021;11:653228.
104.
DenningNLAzizMGurienSDWangP. DAMPs and NETs in sepsis. Front Immunol. 2019;10:2536.
105.
ZuoYZuoMYalavarthiS, et al.Neutrophil extracellular traps and thrombosis in COVID-19. J Thromb Thrombolysis.2021;51(2):446-453.
106.
HazeldineJDinsdaleRJHarrisonPLordJM. Traumatic injury and exposure to mitochondrial-derived damage associated molecular patterns suppresses neutrophil extracellular trap formation. Front Immunol. 2019;10:685.
107.
GebertNJoshiASKutikS, et al.Mitochondrial cardiolipin involved in outer-membrane protein biogenesis: implications for Barth syndrome. Curr Biol. 2009;19(24):2133-2139.
108.
SchlameMGreenbergML. Biosynthesis, remodeling and turnover of mitochondrial cardiolipin. Biochim Biophys Acta Mol Cell Biol Lipids. 2017;1862(1):3-7.
RenMPhoonCKSchlameM. Metabolism and function of mitochondrial cardiolipin. Prog Lipid Res. 2014;55:1-16.
117.
PizzutoMPelegrinP. Cardiolipin in immune signaling and cell death. Trends Cell Biol. 2020;30(11):892-903.
118.
BalasubramanianKMaedaALeeJS, et al.Dichotomous roles for externalized cardiolipin in extracellular signaling: promotion of phagocytosis and attenuation of innate immunity. Sci Signal. 2015;8(395):ra95. doi:10.1126/scisignal.aaa6179
119.
ChuCTJiJDagdaRK, et al.Cardiolipin externalization to the outer mitochondrial membrane acts as an elimination signal for mitophagy in neuronal cells. Nat Cell Biol. 2013;15(10):1197-1205.
120.
NakajimaAKuriharaHYagitaHOkumuraKNakanoH. Mitochondrial extrusion through the cytoplasmic vacuoles during cell death. J Biol Chem.2008;283(35):24128-24135.
121.
WanMHuaXSuJ, et al.Oxidized but not native cardiolipin has pro-inflammatory effects, which are inhibited by annexin A5. Atherosclerosis. 2014;235(2):592-598.
122.
RossenRDMichaelLHHawkinsHK,et al.Cardiolipin-protein complexes and initiation of complement activation after coronary artery occlusion. Circ Res.1994;75(3):546-555.
123.
TanLAYuBSimFCKishoreUSimRB. Complement activation by phospholipids: the interplay of factor H and C1q. Protein Cell. 2010;1(11):1033-1049.
124.
DeguchiHFernandezJAHackengTMBankaCLGriffinJH. Cardiolipin is a normal component of human plasma lipoproteins. Proc Natl Acad Sci USA.2000;97(4):1743-1748.
125.
AntonopoulouSDemopoulosCAIatrouC. Blood cardiolipin in haemodialysis patients. its implication in the biological action of platelet-activating factor. Int J Biochem Cell Biol.1996;28(1):43-51.
126.
AnthonymuthuTSKennyEMHierZE,et al.Detection of brain specific cardiolipins in plasma after experimental pediatric head injury. Exp Neurol. 2019;316:63-73.
127.
ChaoHAnthonymuthuTSKennyEM, et al.Disentangling oxidation/hydrolysis reactions of brain mitochondrial cardiolipins in pathogenesis of traumatic injury. JCI Insight. 2018;3(21):2763‐2772.
128.
LamadeAMAnthonymuthuTSHierZEGaoYKaganVE. Bayır H. Mitochondrial damage & lipid signaling in traumatic brain injury. Exp Neurol. 2020;329:113307.
129.
ZhaoZWangMTianY, et al.Cardiolipin-mediated procoagulant activity of mitochondria contributes to traumatic brain injury-associated coagulopathy in mice. Blood. 2016;127(22):2763-2772.
130.
ChabanVNakstadERStær-JensenH, et al.Complement activation is associated with poor outcome after out-of-hospital cardiac arrest. Resuscitation. 2021;166:129-136.
131.
AnthonymuthuTSKennyEMLamadeAM, et al.Lipidomics detection of brain cardiolipins in plasma is associated with outcome after cardiac arrest. Crit Care Med. 2019;47(4):e292-e300.
132.
RabietMJHuetEBoulayF. Human mitochondria-derived N-formylated peptides are novel agonists equally active on FPR and FPRL1, while Listeria monocytogenes-derived peptides preferentially activate FPR. Eur J Immunol.2005;35(8):2486-2495.
133.
ClaytonDA. Transcription and replication of mitochondrial DNA. Hum Reprod. 2000;15(Suppl 2):11-17.
134.
Fernandez-SilvaPEnriquezJAMontoyaJ. Replication and transcription of mammalian mitochondrial DNA. Exp Physiol.2003;88(1):41-56.
135.
HauserCJOtterbeinLE. Danger signals from mitochondrial DAMPS in trauma and post-injury sepsis. Eur J Trauma Emerg Surg. 2018;44(3):317-324.
136.
LiuMChenKYoshimuraT, et al.Formylpeptide receptors are critical for rapid neutrophil mobilization in host defense against Listeria monocytogenes. Sci Rep. 2012;2:786.
137.
LiuMChenKYoshimuraT, et al.Formylpeptide receptors mediate rapid neutrophil mobilization to accelerate wound healing. PLoS ONE. 2014;9(6):e90613.
138.
CzapigaMGaoJLKirkALekstrom-HimesJ. Human platelets exhibit chemotaxis using functional N-formyl peptide receptors. Exp Hematol. 2005;33(1):73-84.
139.
GrazioliSPuginJ. Mitochondrial damage-associated molecular patterns: from inflammatory signaling to human diseases. Front Immunol. 2018;9:832.
140.
YeRDBoulayFWangJM, et al.International union of basic and clinical pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family. Pharmacol Rev.2009;61(2):119-161.
141.
TorpMKVaageJStensløkkenKO. Mitochondria-derived damage-associated molecular patterns and inflammation in the ischemic-reperfused heart. Acta Physiol.2023;237(3):e13920.
142.
GavinsFN. Are formyl peptide receptors novel targets for therapeutic intervention in ischaemia-reperfusion injury?Trends Pharmacol Sci.2010;31(6):266-276.
143.
McDonaldBPittmanKMenezesGB, et al.Intravascular danger signals guide neutrophils to sites of sterile inflammation. Science. 2010;330(6002):362-366.
144.
DorwardDALucasCDChapmanGBHaslettCDhaliwalKRossiAG. The role of formylated peptides and formyl peptide receptor 1 in governing neutrophil function during acute inflammation. Am J Pathol.2015;185(5):1172-1184.
145.
BeckerELForouharFAGrunnetML, et al.Broad immunocytochemical localization of the formylpeptide receptor in human organs, tissues, and cells. Cell Tissue Res.1998;292(1):129-135.
146.
WenceslauCFSzaszTMcCarthyCGBabanBNeSmithEWebbRC. Mitochondrial N-formyl peptides cause airway contraction and lung neutrophil infiltration via formyl peptide receptor activation. Pulm Pharmacol Ther.2016;37:49-56.
147.
DorwardDALucasCDDohertyMK, et al.Novel role for endogenous mitochondrial formylated peptide-driven formyl peptide receptor 1 signalling in acute respiratory distress syndrome. Thorax. 2017;72(10):928-936.
148.
Martinez-QuinonesPAMcCarthyCGMentzerCJ,et al.Peritoneal cavity lavage reduces the presence of mitochondrial damage associated molecular patterns in open abdomen patients. J Trauma Acute Care Surg. 2017;83(6):1062-1065.
149.
HüttemannMPecinaPRainboltM, et al.The multiple functions of cytochrome c and their regulation in life and death decisions of the mammalian cell: from respiration to apoptosis. Mitochondrion. 2011;11(3):369-381.
150.
KühlbrandtW. Structure and function of mitochondrial membrane protein complexes. BMC Biol. 2015;13:89.
151.
SantucciRSinibaldiFCozzaPPolticelliFFiorucciL. Cytochrome c: an extreme multifunctional protein with a key role in cell fate. Int J Biol Macromol. 2019;136:1237-1246.
152.
WangZBLiMZhaoYXuJX. Cytochrome C is a hydrogen peroxide scavenger in mitochondria. Protein Pept Lett. 2003;10(3):247-253.
153.
ZhaoYWangZBXuJX. Effect of cytochrome c on the generation and elimination of O2*- and H2O2 in mitochondria. J Biol Chem.2003;278(4):2356-2360.
154.
GarridoCGalluzziLBrunetMPuigPEDidelotCKroemerG. Mechanisms of cytochrome c release from mitochondria. Cell Death Differ.2006;13(9):1423-1433.
155.
LiPNijhawanDBudihardjoI,et al.Cytochrome c and dATP-dependent formation of apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell. 1997;91(4):479-489.
156.
OttMZhivotovskyBOrreniusS. Role of cardiolipin in cytochrome c release from mitochondria. Cell Death Differ.2007;14(7):1243-1247.
157.
KaganVEBayirHABelikovaNA, et al.Cytochrome c/cardiolipin relations in mitochondria: a kiss of death. Free Radical Biol Med.2009;46(11):1439-1453.
EleftheriadisTPissasGLiakopoulosVStefanidisI. Cytochrome c as a potentially clinical useful marker of mitochondrial and cellular damage. Front Immunol. 2016;7:279. doi:10.3389/fimmu.2016.00279
160.
JemmersonRLaPlanteBTreefulA. Release of intact, monomeric cytochrome c from apoptotic and necrotic cells. Cell Death Differ.2002;9(5):538-548.
161.
DeneckerGVercammenDSteemansM, et al.Death receptor-induced apoptotic and necrotic cell death: differential role of caspases and mitochondria. Cell Death Differ.2001;8(8):829-840.
162.
RadhakrishnanJWangSAyoubIMKolarovaJDLevineRFGazmuriRJ. Circulating levels of cytochrome c after resuscitation from cardiac arrest: a marker of mitochondrial injury and predictor of survival. Am J Physiol Heart Circ Physiol. 2007;292(2):H767-H775.
163.
SullivanPGKellerJNBussenWLScheffSW. Cytochrome c release and caspase activation after traumatic brain injury. Brain Res. 2002;949(1-2):88-96.
164.
EleftheriadisTPissasGAntoniadiGLiakopoulosVStefanidisI. Damage-associated molecular patterns derived from mitochondria may contribute to the hemodialysis-associated inflammation. Int Urol Nephrol. 2014;46(1):107-112.
165.
AndersenLWLiuXMontissolS, et al.Cytochrome C in patients with septic shock. Shock. 2016;45(5):512-517.
166.
RhodesAEvansLEAlhazzaniW, et al.Surviving sepsis campaign: International guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 2017;43(3):304-377.
167.
BénitPLetouzéERakM, et al.Unsuspected task for an old team: succinate, fumarate and other Krebs cycle acids in metabolic remodeling. Biochim Biophys Acta.2014;1837(8):1330-1337.
168.
MillsEO'NeillLA. Succinate: a metabolic signal in inflammation. Trends Cell Biol. 2014;24(5):313-320.
169.
ZasłonaZO'NeillLAJ. Cytokine-like roles for metabolites in immunity. Mol Cell.2020;78(5):814-823.
170.
McGettrickAFO'NeillLA. How metabolism generates signals during innate immunity and inflammation. J Biol Chem.2013;288(32):22893-22898.
171.
RyanDGMurphyMPFrezzaC,et al.Coupling Krebs cycle metabolites to signalling in immunity and cancer. Nat Metab. 2019;1:16-33. doi:10.1038/s42255-018-0014-7
172.
PeaceCGO'NeillLA. The role of itaconate in host defense and inflammation. J Clin Invest. 2022;132(2):238‐242.
173.
TannahillGMCurtisAMAdamikJ, et al.Succinate is an inflammatory signal that induces IL-1β through HIF-1α. Nature. 2013;496(7444):238-242.
174.
D'AlessandroAMooreHBMooreEE, et al. Plasma succinate is a predictor of mortality in critically injured patients. J Trauma Acute Care Surg. 2017;83(3):491-495.
175.
ReiszJAWitherMJMooreEE, et al.All animals are equal but some animals are more equal than others: plasma lactate and succinate in hemorrhagic shock-a comparison in rodents, swine, nonhuman primates, and injured patients. J Trauma Acute Care Surg. 2018;84(3):537-541.
176.
LiMLiGYuBLuoYLiQ. Activation of hypoxia-inducible factor-1α via succinate dehydrogenase pathway during acute lung injury induced by trauma/hemorrhagic shock. Shock. 2020;53(2):208-216.
177.
NunnsGRVigneshwarNKelherMR, et al.Succinate activation of SUCNR1 predisposes severely injured patients to neutrophil-mediated ARDS. Ann Surg.2022;276(6):e944-ee54.
178.
TaegtmeyerH. Metabolic responses to cardiac hypoxia. Increased production of succinate by rabbit papillary muscles. Circ Res.1978;43(5):808-815.
179.
PragHAGruszczykAVHuangMM, et al.Mechanism of succinate efflux upon reperfusion of the ischaemic heart. Cardiovasc Res.2021;117(4):1188-1201.
180.
ForresterSJKikuchiDSHernandesMSXuQGriendlingKK. Reactive oxygen species in metabolic and inflammatory signaling. Circ Res.2018;122(6):877-902.
181.
MurphyMP. How mitochondria produce reactive oxygen species. Biochem J.2009;417(1):1-13.
SandangerORanheimTVingeLE, et al.The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemia-reperfusion injury. Cardiovasc Res.2013;99(1):164-174.
184.
RemijsenQVanden BergheTWirawanE, et al.Neutrophil extracellular trap cell death requires both autophagy and superoxide generation. Cell Res.2011;21(2):290-304.
185.
SilwalPKimJKKimYJJoEK. Mitochondrial reactive oxygen species: double-edged weapon in host defense and pathological inflammation during infection. Front Immunol. 2020;11:1649.
186.
PrandiniPDe LoguFFusiC, et al.Transient receptor potential ankyrin 1 channels modulate inflammatory response in respiratory cells from patients with cystic fibrosis. Am J Respir Cell Mol Biol.2016;55(5):645-656.
187.
Di VirgilioFSartiACCoutinho-SilvaR. Purinergic signaling, DAMPs, and inflammation. Am J Physiol Cell Physiol. 2020;318(5):C832-C8c5.
188.
DoschMGerberJJebbawiFBeldiG. Mechanisms of ATP release by inflammatory cells. Int J Mol Sci.2018;19(4):201‐212.
TorpM-KYangKRanheimT, et al.Mammalian target of rapamycin (mTOR) and the proteasome attenuates IL-1β expression in primary mouse cardiac fibroblasts. Front Immunol.2019;10(1285):358‐404.
191.
BoursMJSwennenELDi VirgilioFCronsteinBNDagneliePC. Adenosine 5′-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. Pharmacol Ther.2006;112(2):358-404.
192.
ElliottMRChekeniFBTrampontPC, et al.Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance. Nature. 2009;461(7261):282-286.
193.
IdzkoMFerrariDEltzschigHK. Nucleotide signalling during inflammation. Nature. 2014;509(7500):310-317.
194.
FaroqiAHLimMJKeeEC, et al.In vivo detection of extracellular adenosine triphosphate in a mouse model of traumatic brain injury. J Neurotrauma. 2021;38(5):655-664.
195.
DixitACheemaHGeorgeJ,et al.Extracellular release of ATP promotes systemic inflammation during acute pancreatitis. Am J Physiol Gastrointest Liver Physiol. 2019;317(4):G463-Gg75.
196.
CsókaBNémethZHTörőG, et al.Extracellular ATP protects against sepsis through macrophage P2X7 purinergic receptors by enhancing intracellular bacterial killing. FASEB J.2015;29(9):3626-3637.
197.
SumiYWoehrleTChenY, et al.Plasma ATP is required for neutrophil activation in a mouse sepsis model. Shock. 2014;42(2):142-147.
198.
DoschMZindelJJebbawiF, et al.Connexin-43-dependent ATP release mediates macrophage activation during sepsis. eLife. 2019;8:1577‐1586.
199.
StachonPGeisSPeikertA, et al.Extracellular ATP induces vascular inflammation and atherosclerosis via purinergic receptor Y2 in mice. Arterioscler, Thromb, Vasc Biol.2016;36(8):1577-1586.
200.
QuirogaJAlarcónPManosalvaC, et al.Mitochondria-derived ATP participates in the formation of neutrophil extracellular traps induced by platelet-activating factor through purinergic signaling in cows. Dev Comp Immunol.2020;113:103768.
201.
MartinCLeoneMViviandXAyemMLGuieuR. High adenosine plasma concentration as a prognostic index for outcome in patients with septic shock. Crit Care Med. 2000;28(9):3198-3202.
202.
HoVMHirohashiNKongWS, et al.Sera from septic patients contain the inhibiting activity of the extracellular ATP-dependent inflammasome pathway. Tohoku J Exp Med. 2018;245(3):193-204.
203.
ScarpullaRC. Transcriptional paradigms in mammalian mitochondrial biogenesis and function. Physiol Rev.2008;88(2):611-638.
204.
LarssonNGWangJWilhelmssonH, et al.Mitochondrial transcription factor A is necessary for mtDNA maintenance and embryogenesis in mice. Nat Genet. 1998;18(3):231-236.
205.
KohJHKimYWSeoDYSohnTS. Mitochondrial TFAM as a signaling regulator between cellular organelles: a perspective on metabolic diseases. Diabetes Metab J. 2021;45(6):853-865.
206.
KaufmanBADurisicNMativetskyJM,et al.The mitochondrial transcription factor TFAM coordinates the assembly of multiple DNA molecules into nucleoid-like structures. Mol Biol Cell. 2007;18(9):3225-3236.
207.
KangDKimSHHamasakiN. Mitochondrial transcription factor A (TFAM): roles in maintenance of mtDNA and cellular functions. Mitochondrion. 2007;7(1-2):39-44.
208.
LittleJPSimtchoukSSchindlerSM, et al.Mitochondrial transcription factor A (Tfam) is a pro-inflammatory extracellular signaling molecule recognized by brain microglia. Mol Cell Neurosci. 2014;60:88-96.
209.
JulianMWShaoGBaoS,et al.Mitochondrial transcription factor A serves as a danger signal by augmenting plasmacytoid dendritic cell responses to DNA. J Immunol. 2012;189(1):433-443.
210.
ChaungWWWuRJiYDongWWangP. Mitochondrial transcription factor A is a proinflammatory mediator in hemorrhagic shock. Int J Mol Med. 2012;30(1):199-203.
211.
RahmelTMarkoBNowakH, et al.Mitochondrial dysfunction in sepsis is associated with diminished intramitochondrial TFAM despite its increased cellular expression. Sci Rep. 2020;10(1):21029.
212.
BhowalCGhoshSGhatakDDeR. Pathophysiological involvement of host mitochondria in SARS-CoV-2 infection that causes COVID-19: a comprehensive evidential insight. Mol Cell Biochem.2023;478(6):1325-1343.
213.
PrasunP. COVID-19: A mitochondrial perspective. DNA Cell Biol. 2021;40(6):713-719.
214.
ChenZZJohnsonLTrahtembergU, et al.Mitochondria and cytochrome components released into the plasma of severe COVID-19 and ICU acute respiratory distress syndrome patients. Clin Proteomics. 2023;20(1):17.
215.
ScozziDCanoMMaL, et al.Circulating mitochondrial DNA is an early indicator of severe illness and mortality from COVID-19. JCI Insight. 2021;6(4):1256042.
216.
ShorakaSMohebbiSRHosseiniSMZaliMR. Comparison of plasma mitochondrial DNA copy number in asymptomatic and symptomatic COVID-19 patients. Front Microbiol. 2023;14:1256042.
217.
Valdés-AguayoJJGarza-VelozIVargas-RodríguezJR, et al.Peripheral blood mitochondrial DNA levels were modulated by SARS-CoV-2 infection severity and its lessening was associated with mortality among hospitalized patients with COVID-19. Front Cell Infect Microbiol. 2021;11:754708.
218.
SzturmowiczMDemkowU. Neutrophil extracellular traps (NETs) in severe SARS-CoV-2 lung disease. Int J Mol Sci.2021;22(16):1059‐1063.
219.
HendersonLACannaSWSchulertGS, et al.On the alert for cytokine storm: immunopathology in COVID-19. Arthritis Rheumatol. 2020;72(7):1059-1063.
220.
LeppkesMKnopfJNaschbergerE, et al.Vascular occlusion by neutrophil extracellular traps in COVID-19. EBioMedicine. 2020;58:102925.
221.
SchapherMKochMWeidnerD, et al.Neutrophil extracellular traps promote the development and growth of human salivary stones. Cells. 2020;9(9):e20200652.
222.
BarnesBJAdroverJMBaxter-StoltzfusA, et al.Targeting potential drivers of COVID-19: neutrophil extracellular traps. J Exp Med. 2020;217(6):449‐460.
223.
LianaPLibertyIAMurtiK,et al.A systematic review on neutrophil extracellular traps and its prognostication role in COVID-19 patients. Immunol Res. 2022;70(4):449-460.
224.
LeeSJYoonTHaJW, et al.Prevalence, clinical significance, and persistence of autoantibodies in COVID-19. Virol J. 2023;20(1):236.
225.
FonsecaDLMFilgueirasISMarquesAHC, et al.Severe COVID-19 patients exhibit elevated levels of autoantibodies targeting cardiolipin and platelet glycoprotein with age: a systems biology approach. NPJ Aging. 2023;9(1):21.
226.
BertinDBrodovitchALopezA, et al.Anti-cardiolipin IgG autoantibodies associate with circulating extracellular DNA in severe COVID-19. Sci Rep. 2022;12(1):12523.
227.
Baiges-GayaGIftimieSCastañéH, et al.Combining semi-targeted metabolomics and machine learning to identify metabolic alterations in the serum and urine of hospitalized patients with COVID-19. Biomolecules. 2023;13(1):154739.
228.
ShiDYanRLvL, et al.The serum metabolome of COVID-19 patients is distinctive and predictive. Metabolism. 2021;118:154739.
229.
Ceperuelo-MallafréVRevertéLPeraireJ, et al.Circulating pyruvate is a potent prognostic marker for critical COVID-19 outcomes. Front Immunol. 2022;13:912579.
230.
KuleyRDuvvuriBWallinJJ, et al.Mitochondrial N-formyl methionine peptides contribute to exaggerated neutrophil activation in patients with COVID-19. Virulence. 2023;14(1):2218077.
231.
da SilvaGBManicaDda SilvaAP, et al.High levels of extracellular ATP lead to different inflammatory responses in COVID-19 patients according to the severity. J Mol Med.2022;100(4):645-663.
232.
RaposoGStahlPD. Extracellular vesicles: a new communication paradigm?Nat Rev Mol Cell Biol.2019;20(9):509-510.
233.
StahlPDRaposoG. Extracellular vesicles: exosomes and microvesicles, integrators of homeostasis. Physiology (Bethesda). 2019;34(3):169-177.
234.
van NielGCarterDRFClaytonALambertDWRaposoGVaderP. Challenges and directions in studying cell-cell communication by extracellular vesicles. Nat Rev Mol Cell Biol.2022;23(5):369-382.
235.
SimonsMRaposoG. Exosomes–vesicular carriers for intercellular communication. Curr Opin Cell Biol.2009;21(4):575-581.
236.
Mato-BasaloRLucio-GallegoSAlarcón-VeleiroC, et al.Action mechanisms of small extracellular vesicles in inflammaging. Life (Basel). 2022;12(4):1525‐1544.
237.
WeberBFranzNMarziIHenrichDLeppikL. Extracellular vesicles as mediators and markers of acute organ injury: current concepts. Eur J Trauma Emerg Surg. 2022;48(3):1525-1544.
238.
ZhouYKPatelHHRothDM. Extracellular vesicles: a new paradigm for cellular communication in perioperative medicine, critical care, and pain management. Anesth Analg. 2021;133(5):1162-1179.
239.
TorralbaDBaixauliFSánchez-MadridF. Mitochondria know no boundaries: mechanisms and functions of intercellular mitochondrial transfer. Front Cell Dev Biol. 2016;4:107. doi:10.3389/fcell.2016.00107
240.
CaicedoAZambranoKSanonS, et al.The diversity and coexistence of extracellular mitochondria in circulation: a friend or foe of the immune system. Mitochondrion. 2021;58:270-284.
241.
PuhmFAfonyushkinTReschU, et al.Mitochondria are a subset of extracellular vesicles released by activated monocytes and induce type I IFN and TNF responses in endothelial cells. Circ Res.2019;125(1):43-52.
242.
MiliotisSNicolaldeBOrtegaMYepezJCaicedoA. Forms of extracellular mitochondria and their impact in health. Mitochondrion. 2019;48:16-30.
243.
AmariLGermainM. Mitochondrial extracellular vesicles—origins and roles. Front Mol Neurosci. 2021;14:767219.
244.
SanwlaniRGangodaL. Role of extracellular vesicles in cell death and inflammation. Cells. 2021;10(10):137‐143.
245.
YamamotoSAzumaEMuramatsuMHamashimaTIshiiYSasaharaM. Significance of extracellular vesicles: pathobiological roles in disease. Cell Struct Funct. 2016;41(2):137-143.
246.
ZhuMBarbasASLinLScheuermannUBishawiMBrennanTV. Mitochondria released by apoptotic cell death initiate innate immune responses. Immunohorizons. 2018;2(11):384-397.
247.
HessvikNPLlorenteA. Current knowledge on exosome biogenesis and release. Cell Mol Life Sci. 2018;75(2):193-208.
248.
GurungSPerocheauDTouramanidouLBaruteauJ. The exosome journey: from biogenesis to uptake and intracellular signalling. Cell Commun Signal. 2021;19(1):47.
249.
XianHLiuYRundberg NilssonA, et al.Metformin inhibition of mitochondrial ATP and DNA synthesis abrogates NLRP3 inflammasome activation and pulmonary inflammation. Immunity. 2021;54(7):1463-1477. e11.
250.
ChernegaTChoiJSalmenaLAndreazzaAC. Mitochondrion-targeted RNA therapies as a potential treatment strategy for mitochondrial diseases. Mol Ther Nucleic Acids. 2022;30:359-377.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
